Esperion Therapeutics
ESPR
#6169
Rank
HK$6.88 B
Marketcap
HK$29.04
Share price
-1.58%
Change (1 day)
11.72%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$6.34 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are HK$6.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$5.68 B10.2%
2023-12-31HK$5.16 B15.53%
2022-12-31HK$4.46 B-0.98%
2021-12-31HK$4.51 B29.49%
2020-12-31HK$3.48 B129.99%
2019-12-31HK$1.51 B200.68%
2018-12-31HK$0.50 B94.55%
2017-12-31HK$0.25 B101.03%
2016-12-31HK$0.12 B99.92%
2015-12-31HK$64.43 M-14.56%
2014-12-31HK$75.4 M131.37%
2013-12-31HK$32.59 M-82.98%
2012-12-31HK$0.19 B199.3%
2011-12-31HK$63.97 M
2002-12-31HK$98.76 M6.95%
2001-12-31HK$92.33 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
HK$9.14 B 44.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$12.12 B 91.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$900.17 B 14,081.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$71.70 B 1,029.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$4.96 B-21.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
HK$0.66 B-89.48%๐Ÿ‡บ๐Ÿ‡ธ USA